secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLx Pharma Winddown Corp. (—)
CIK:        0001497504
Form:       8-K
Filed at:   2023-04-10T23:59:59+00:00
Accession:  0001193805-23-000530
Event type: regulatory
Sentiment:  negative
Materiality: 0.95
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PLx Pharma receives Nasdaq delisting notice; stock to be suspended April 13
---------------------------------------------------------------------------

- Nasdaq notified PLx Pharma on April 4, 2023 that it failed to regain compliance with minimum bid price rule ($1.00) and is not eligible for second 180-day period.
- Company's estimated pro-forma equity as of March 31, 2023 was below $5 million; also failed to file Form 10-K for FY2022.
- Company will not appeal; trading suspension expected at opening on April 13, 2023, followed by delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1497504/000119380523000530/0001193805-23-000530-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1497504/000119380523000530/e618485_8k-plx.htm
  HTML page:      https://secwatch.observer/filing/0001193805-23-000530

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer